Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor.
William G WierdaJohn C ByrdMatthew S DavidsRichard R FurmanBruce D ChesonPaul M BarrHerbert EradatLeonard HeffnerLang ZhouMaria VerdugoJalaja PotluriMichael ChoiPublished in: British journal of haematology (2018)
Keyphrases